Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melanoma risk for CDKN2A mutation carriers who are relatives of population-based case carriers in Australia and the UK.
Cust AE, Harland M, Makalic E, Schmidt D, Dowty JG, Aitken JF, Agha-Hamilton C, Armstrong BK, Barrett JH, Chan M, Chang YM, Gascoyne J, Giles GG, Holland EA, Kefford RF, Kukalizch K, Lowery J, Randerson-Moor JA, Schmid H, Taylor CF, Whitaker L, Hopper JL, Newton-Bishop JA, Mann GJ, Bishop DT, Jenkins MA. Cust AE, et al. Among authors: harland m. J Med Genet. 2011 Apr;48(4):266-72. doi: 10.1136/jmg.2010.086538. Epub 2011 Feb 15. J Med Genet. 2011. PMID: 21325014 Free PMC article.
Germline mutations of the CDKN2 gene in UK melanoma families.
Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr NK, Frischauf AM, Bataille V, Peters G, Cuzick J, Selby P, Bishop DT, Bishop JN. Harland M, et al. Hum Mol Genet. 1997 Nov;6(12):2061-7. doi: 10.1093/hmg/6.12.2061. Hum Mol Genet. 1997. PMID: 9328469
The genetics of melanoma: the UK experience.
Newton Bishop JA, Harland M, Bishop DT. Newton Bishop JA, et al. Among authors: harland m. Clin Exp Dermatol. 1998 Jul;23(4):158-61. doi: 10.1046/j.1365-2230.1998.00344.x. Clin Exp Dermatol. 1998. PMID: 9894359 Review.
Mutation testing in melanoma families: INK4A, CDK4 and INK4D.
Newton Bishop JA, Harland M, Bennett DC, Bataille V, Goldstein AM, Tucker MA, Ponder BA, Cuzick J, Selby P, Bishop DT. Newton Bishop JA, et al. Among authors: harland m. Br J Cancer. 1999 Apr;80(1-2):295-300. doi: 10.1038/sj.bjc.6690354. Br J Cancer. 1999. PMID: 10390011 Free PMC article.
Mutation screening of the CDKN2A promoter in melanoma families.
Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarrà G, Goldstein AM, Tucker MA, Ponder BA, Mann GJ, Bishop DT, Newton Bishop J. Harland M, et al. Genes Chromosomes Cancer. 2000 May;28(1):45-57. Genes Chromosomes Cancer. 2000. PMID: 10738302
Geographical variation in the penetrance of CDKN2A mutations for melanoma.
Bishop DT, Demenais F, Goldstein AM, Bergman W, Bishop JN, Bressac-de Paillerets B, Chompret A, Ghiorzo P, Gruis N, Hansson J, Harland M, Hayward N, Holland EA, Mann GJ, Mantelli M, Nancarrow D, Platz A, Tucker MA; Melanoma Genetics Consortium. Bishop DT, et al. Among authors: harland m. J Natl Cancer Inst. 2002 Jun 19;94(12):894-903. doi: 10.1093/jnci/94.12.894. J Natl Cancer Inst. 2002. PMID: 12072543
Intronic sequence variants of the CDKN2A gene in melanoma pedigrees.
Harland M, Taylor CF, Bass S, Churchman M, Randerson-Moor JA, Holland EA, Mann GJ, Bishop DT, Newton Bishop JA. Harland M, et al. Genes Chromosomes Cancer. 2005 Jun;43(2):128-36. doi: 10.1002/gcc.20177. Genes Chromosomes Cancer. 2005. PMID: 15761864
137 results